CVS Health EBITDA 2010-2024 | CVS
CVS Health annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- CVS Health EBITDA for the quarter ending September 30, 2024 was $1.993B, a 58.63% decline year-over-year.
- CVS Health EBITDA for the twelve months ending September 30, 2024 was $14.105B, a 22.94% decline year-over-year.
- CVS Health 2023 annual EBITDA was $18.109B, a 48.7% increase from 2022.
- CVS Health 2022 annual EBITDA was $12.178B, a 33.19% decline from 2021.
- CVS Health 2021 annual EBITDA was $18.227B, a 0.68% decline from 2020.
CVS Health Annual EBITDA
(Millions of US $) |
| 2023 |
$18,109 |
| 2022 |
$12,178 |
| 2021 |
$18,227 |
| 2020 |
$18,352 |
| 2019 |
$16,358 |
| 2018 |
$12,888 |
| 2017 |
$12,198 |
| 2016 |
$12,861 |
| 2015 |
$11,567 |
| 2014 |
$10,730 |
| 2013 |
$9,907 |
| 2012 |
$8,963 |
| 2011 |
$7,899 |
| 2010 |
$7,606 |
| 2009 |
$7,814 |
CVS Health Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
$1,993 |
| 2024-06-30 |
$4,196 |
| 2024-03-31 |
$3,409 |
| 2023-12-31 |
$4,507 |
| 2023-09-30 |
$4,817 |
| 2023-06-30 |
$4,338 |
| 2023-03-31 |
$4,447 |
| 2022-12-31 |
$4,702 |
| 2022-09-30 |
$-2,869 |
| 2022-06-30 |
$5,751 |
| 2022-03-31 |
$4,594 |
| 2021-12-31 |
$3,435 |
| 2021-09-30 |
$4,626 |
| 2021-06-30 |
$5,463 |
| 2021-03-31 |
$4,703 |
| 2020-12-31 |
$3,663 |
| 2020-09-30 |
$4,363 |
| 2020-06-30 |
$5,782 |
| 2020-03-31 |
$4,544 |
| 2019-12-31 |
$4,133 |
| 2019-09-30 |
$4,020 |
| 2019-06-30 |
$4,404 |
| 2019-03-31 |
$3,801 |
| 2018-12-31 |
$3,859 |
| 2018-09-30 |
$3,194 |
| 2018-06-30 |
$3,195 |
| 2018-03-31 |
$2,640 |
| 2017-12-31 |
$3,797 |
| 2017-09-30 |
$3,114 |
| 2017-06-30 |
$2,875 |
| 2017-03-31 |
$2,412 |
| 2016-12-31 |
$3,648 |
| 2016-09-30 |
$3,435 |
| 2016-06-30 |
$2,976 |
| 2016-03-31 |
$2,802 |
| 2015-12-31 |
$3,332 |
| 2015-09-30 |
$2,863 |
| 2015-06-30 |
$2,750 |
| 2015-03-31 |
$2,622 |
| 2014-12-31 |
$2,810 |
| 2014-09-30 |
$2,723 |
| 2014-06-30 |
$2,696 |
| 2014-03-31 |
$2,501 |
| 2013-12-31 |
$2,675 |
| 2013-09-30 |
$2,615 |
| 2013-06-30 |
$2,421 |
| 2013-03-31 |
$2,196 |
| 2012-12-31 |
$2,740 |
| 2012-09-30 |
$2,257 |
| 2012-06-30 |
$2,139 |
| 2012-03-31 |
$1,827 |
| 2011-12-31 |
$2,354 |
| 2011-09-30 |
$1,991 |
| 2011-06-30 |
$1,875 |
| 2011-03-31 |
$1,679 |
| 2010-12-31 |
$2,121 |
| 2010-09-30 |
$1,848 |
| 2010-06-30 |
$1,869 |
| 2010-03-31 |
$1,768 |
| 2009-12-31 |
$2,234 |
| 2009-09-30 |
$1,867 |
| 2009-06-30 |
$1,982 |
| 2009-03-31 |
$1,731 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$55.823B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
